Selected References
- Schmidt KG, Harrer EG, Schönau V, Simon D, Kleyer A, Steininger P, Korn K, Schett G, Knobloch CS, Nganou‑Makamdop K*, Harrer T*. Detection of pre‑existing neutralizing antibodies against Ad26 in HIV‑1‑infected individuals not responding to the Ad26.COV2.S vaccine. Infection. 2023 Apr 17:1-11. * Shared last author.
- Fischhaber N*, Schmiedeberg M*, Kübel S, Harrer EG, Harrer T, Nganou-Makamdop K. Ex vivo blockade of the PD-1 pathway improves recall IFNg responses of HIV-infected persons on antiretroviral therapy. Vaccines 2023 11(2): 211.
- El Kenz B, Schmidt KG, Ogungbemi-Alt VK, Bergmann S, Steininger P, Korn K, Spriewald B, Harrer EG, Nganou-Makamdop K*, Harrer T*. Definition of a New HLA B*52-Restricted Rev CTL Epitope Targeted by an HIV-1-Infected Controller. Viruses 2023 15(2): 567. doi:10.3390/v15020567* Shared last author.
- Schmidt K, Harrer E.G, Tascilar K, Kubel S, El Kenz B, Hartmann F, Simon D, Schett G, Nganou-Makamdop K*, Harrer T*. Characterization of serum and mucosal SARS-CoV2 antibodies in HIV-1-infected subjects after BNT162b2 mRNA vaccination or SARS-CoV-2 infection. Viruses 2022, 14 (3) 651. * Shared last author
- Nganou-Makamdop K*, Talla A*, Sharma AS*, Darko S, Ransier A, Laboune F, Chipman JG, Beilman GJ, Hodskuldsson T, Fourati S, Schmidt TE, Arumugam S, Lima NS, Moon D, Callisto S, Schoephoerster J, Tomalka J, Mugyenyi P, Ssali F, Muloma P, Ssengendo P, Leda AR, Cheu RK, Flynn JK, Morou A, Brunet-Ratnasingham E, Rodriguez B, Lederman MM, Kaufmann DE, Klatt NR, Kityo C, Brenchley JM, Schacker TW, Sekaly RP, Douek DC. Translocated microbiome composition determines immunological outcome in treated HIV infection. Cell 2021; July -3899-3914.e16. *Shared first author.
- Schmidt KG, Nganou-Makamdop K, Tenbusch M, El Kenz B, Maier C, Lapuente D, Überla K, Spriewald B, Bergmann S, Harrer EG, Harrer T. SARS-CoV-2-Seronegative subjects target CTL epitopes in the SARS-CoV2 nucleoprotein cross-reactive to common cold coronaviruses. Front. Immunol. 2021 Apr 28:12:627568.
- Morou A, Brunet-Ratnasingham E, Dube M, Charlebois R, Mercier E, Darko S, Brassard N, Nganou-Makamdop K, Arumugam S, Gendron-Lepage G, Yang L, Niessl J, Baxter AE, Billingsley JM, Rajakumar PA, Lefebvre F, Johnson RP, Tremblay C, Routy JP, Wyatt RT, Finzi A, Douek DC, Kaufmann DE. Altered differentiation is central to HIV-specific CD4+ T cell dysfunction in progressive disease. Nature Immunol. 2019Aug;20(8):1059-1070.
